Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Experimental & Molecular Medicine ; : 509-518, 2006.
Artigo em Inglês | WPRIM | ID: wpr-69447

RESUMO

Angiotensin II (Ang II), which is an important mediator of both vascular responsiveness and growth, has been shown to induce vascular smooth muscle cell (VSMC) hypertrophy via the activation of a complex series of intracellular signaling events. Heat shock protein 70 (Hsp70) has recently been shown to protect against Ang II-induced hypertension. In this study, we tested the hypothesis that Hsp70 can protect VSMC from Ang II-induced hypertrophy. We treated VSMCs with Ang II to induce hypertrophy and to activate MAPK signaling pathway. We observed that the augmentation of Hsp70 expression inhibited Ang II-stimulated VSMC hypertrophy. This inhibitory effect of Hsp70 appears to be partly due to extracellular signal-regulated kinase (ERK1/2) inactivation, which in turn, may possibly result from the accumulation of MAP kinase phosphatase-1 (MKP-1).


Assuntos
Ratos , Masculino , Animais , Ratos Sprague-Dawley , RNA Interferente Pequeno/farmacologia , Proteínas Tirosina Fosfatases/metabolismo , Fosfoproteínas Fosfatases/metabolismo , Músculo Liso Vascular/citologia , Proteína Quinase 3 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , MAP Quinase Quinase 2/metabolismo , MAP Quinase Quinase 1/metabolismo , Proteínas Imediatamente Precoces/metabolismo , Hipertrofia , Proteínas de Choque Térmico HSP70/antagonistas & inibidores , Flavonoides/farmacologia , Estabilidade Enzimática/efeitos dos fármacos , Células Cultivadas , Proteínas de Ciclo Celular/metabolismo , Aorta/efeitos dos fármacos , Angiotensina II/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA